Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127670411 | 12767041 | 1 | I | 20160913 | 20160921 | 20160921 | EXP | DE-ACTELION-A-US2016-142581 | ACTELION | 0.00 | F | Y | 0.00000 | 20160921 | OT | DE | RU |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127670411 | 12767041 | 1 | PS | VENTAVIS | ILOPROST | 1 | Respiratory (inhalation) | 6X/DAILY | U | U | 21779 | INHALATION VAPOUR, SOLUTION | |||||||
| 127670411 | 12767041 | 2 | SS | TRACLEER | BOSENTAN | 1 | Oral | U | U | 21290 | TABLET | ||||||||
| 127670411 | 12767041 | 3 | SS | SILDENAFIL. | SILDENAFIL | 1 | Unknown | U | U | 0 | |||||||||
| 127670411 | 12767041 | 4 | C | OPSUMIT | MACITENTAN | 1 | Oral | U | 204410 | TABLET | |||||||||
| 127670411 | 12767041 | 5 | C | VEROSPIRON | SPIRONOLACTONE | 1 | U | 0 | |||||||||||
| 127670411 | 12767041 | 6 | C | FUROSEMIDE. | FUROSEMIDE | 1 | U | 0 | |||||||||||
| 127670411 | 12767041 | 7 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | U | 0 | |||||||||||
| 127670411 | 12767041 | 8 | C | BETALOC | METOPROLOL TARTRATE | 1 | U | 0 | |||||||||||
| 127670411 | 12767041 | 9 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | U | 0 | |||||||||||
| 127670411 | 12767041 | 10 | C | DIGOXIN. | DIGOXIN | 1 | U | 0 | |||||||||||
| 127670411 | 12767041 | 11 | C | DICARB | 2 | U | 0 | ||||||||||||
| 127670411 | 12767041 | 12 | C | ACETAZOLAMIDE. | ACETAZOLAMIDE | 1 | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127670411 | 12767041 | 1 | Pulmonary arterial hypertension |
| 127670411 | 12767041 | 2 | Pulmonary arterial hypertension |
| 127670411 | 12767041 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127670411 | 12767041 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127670411 | 12767041 | Cardiac failure | |
| 127670411 | 12767041 | Chest pain | |
| 127670411 | 12767041 | Dyspnoea exertional | |
| 127670411 | 12767041 | Erythema | |
| 127670411 | 12767041 | Heart rate increased | |
| 127670411 | 12767041 | Intentional product misuse | |
| 127670411 | 12767041 | Oedema | |
| 127670411 | 12767041 | Oedema peripheral | |
| 127670411 | 12767041 | Transaminases increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |